<< November 2018 >>
        1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30  

Add an event...

September 2018

Thursday, September 27
Crack The Code: 3 Defining Steps To Unlock Your Medical Technology's Commercialization Potential - 9/27 - Missoula
4:30 PM
Gilkey Building University of Montana
Telos Partners, together with First Security Bank and Accelerate Montana, present Crack the Code: 3 Defining Steps to Unlock Your Medical Technology's Commercialization Potential

Embarking on the journey of commercializing your medical technology can be an ominous and daunting task, with questions regarding regulation, reimbursement, adoption, intellectual property, funding and distribution. We aim to help in answering these questions in an effort to assist biotech, drug, and medical device start-ups succeed.

This event will include an interactive presentation moderated by Telos Partners' founder, Joel Batts, along with distinguished panelists Samir Bhattacharyya, PhD (Johnson & Johnson), Bill Cimino, PhD, (The GID Group) and Dennis O'Brien (Linn Grove Venture Capital).

The audience will learn from both "successes" and "failures" described throughout the presentation. Interaction with the speaker and panelists will provide insights you can implement now. Access to resources will also be available. You won't want to miss it!

Thursday, September 27th, 2018 from 4:30 PM - 8:30 PM Gilkey Building - University of Montana, 32 Campus Drive, Missoula

If you wish to view more details or to register for the event, please visit:

Speakers and Panelists include:

Joel Batts | President, Co-Founder Telos Partners, LLC

Biomedical industry veteran

20 years leadership experience developing scientific and regulatory

Delivered >$100 million return on investment by delivering FDA approvals for Class II and Class III devices

Published and presented results of pre-clinical and clinical science in journals and global stage venues

Led a business development team in the application of a novel biologic material to osteoporotic patients for reducing the incidence of hip fractures. Technology acquired for $30 million.

Led key areas of investment and integration for four major acquisitions.

Outside of Telos Partners, Joel is part of LifeNet International, a non-profit that is transforming healthcare in African communities. Joel earned a BS in exercise science from the University of Florida and an MA in bioethics and health policy from Loyola University Chicago.

Samir Bhattacharyya, PhD | Head, Health Economics and Market Access, US Depuy Synthes

20 years of global experience in the medical device, pharmaceutical, and biotechnology industries.

Leadership positions in sales & marketing, pricing & reimbursement, health economics, market access, and clinical research & development.

Has built and led best-in-class functions and teams in companies experiencing major growth.

Prior to joining Johnson & Johnson, Dr. Bhattacharyya was a Vice President of Market Access Services at Covance. Prior to joining Covance, Samir was a senior director of marketing at Baxter Healthcare Corporation. Dr. Bhattacharyya also worked for Amgen, Pfizer (Pharmacia), and Procter & Gamble. Therapeutic experience includes orthopedic, nephrology, oncology, cardiovascular, sports medicine, urology, and infectious diseases.

Published widely in peer reviewed journals in the field of health economics and outcomes research.

PhD in Pharmacoeconomics from the University of Arizona Pharmacy School and MS in Economics from the Eller College of Management at the University of Arizona.

Dennis O'Brien | Partner, Linn Grove Venture Capital

Broad leadership background in manufacturing and sales & marketing in the medical products industry. 15 years with Bausch and Lomb as General Manager of Canadian operations, Vice President of Global Refractive Surgery and, most recently, as VP and GM of US Surgical operations.

Director and Officer of Next Healthcare, a North Dakota cell therapeutics start-up offering the CelBank service.

Vast medical experience in strategic marketing, including developing and managing supplier agreements, license agreements and strategic acquisitions.

Highly knowledgeable in the areas of manufacturing, domestic and international logistics, upstream marketing & strategy, as well as commercial operations.

BS in Chemical Engineering from Rensselaer Polytechnic Institute and business study at the Simon School, University of Rochester and Columbia Business School.

Holds 3 US patents.


E-mail this page to a friend!